Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 12:12 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 183 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Women Contraception Clear all

Conditions: Contraception
Interventions: Counseling; Other
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 49 Years · Female only
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: HIV Infections
Interventions: Ethinyl estradiol/levonorgestrel, Medroxyprogesterone acetate; Drug
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 16 Years to 35 Years · Female only
Enrollment: 6,360 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1999 – 2002
U.S. locations: 1
States / cities: Research Triangle Park, North Carolina

Conditions: Reproductive Sterilization
Interventions: Adiana Transcervical Sterilization System; Device
Lead sponsor: Hologic, Inc.; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 770 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2013
U.S. locations: 14
States / cities: Phoenix, Arizona • Roseville, California • San Rafael, California + 11 more

Conditions: Cystitis, Interstitial, Dysmenorrhea, Migraine Disorders, Pelvic Pain, Endometriosis, Visceral Pain, Chronic Pain
Interventions: cyclic microgestin 1/20, continuous microgestin 1/20; Drug
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 353 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Diabetes, Gestational
Interventions: Physical Activity Intervention, Wellness Education; Behavioral · Other
Lead sponsor: The University of Tennessee, Knoxville; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Knoxville, Tennessee

Conditions: Pregnancy, Breastfeeding, Contraception, Cervical Cancer, Postpartum Depression
Interventions: Postpartum follow up appointment 2-3 weeks after delivery, Postpartum follow up 6-8wk after delivery; Other
Lead sponsor: Madigan Army Medical Center; Federal
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 344 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Tacoma, Washington

Conditions: Birth Control
Interventions: WC then FC2, FC2 then WC; Device
Lead sponsor: CONRAD; Other
Eligibility: 18 Years and older
Enrollment: 505 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Opiate Addiction, Pregnancy, Contraceptive Behavior, Sexual Behavior
Interventions: Nexplanon (etonogestrel contraceptive implant), Standard postpartum contraceptive care; Drug
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older · Female only
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Insulin Sensitivity, Cardiovascular Risk, Perimenopausal Disorder
Interventions: Ortho Cyclen®; Drug
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Opioid-use Disorder, Contraception, Neonatal Abstinence Syndrome
Interventions: Motivational Interviewing and Educational Training (MIET); Behavioral
Lead sponsor: Meharry Medical College; Other
Eligibility: 18 Years to 44 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Contraception
Interventions: LNG-EC, UPA-EC; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Healthy Women, Female Contraception
Interventions: NES-E2 CVR; Drug
Lead sponsor: Premier Research; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 385 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 11
States / cities: Los Angeles, California • Sacramento, California • Aurora, Colorado + 7 more

Conditions: Contraception
Interventions: Subcutaneous depot medroxyprogesterone acetate; Drug
Lead sponsor: Planned Parenthood Federation of America; Other
Eligibility: 15 Years to 44 Years · Female only
Enrollment: 401 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 2
States / cities: Morristown, New Jersey • Houston, Texas

Conditions: Healthy Women, Female Contraception
Interventions: Mona Lisa® NT Cu380 Mini, ParaGard® TCu380A; Drug
Lead sponsor: FHI 360; Other
Eligibility: 16 Years to 40 Years · Female only
Enrollment: 1,105 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 16
States / cities: Los Angeles, California • Sacramento, California • San Francisco, California + 11 more

Conditions: Contraception
Interventions: group family planning counseling, Individual family planning counseling; Behavioral
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years and older · Female only
Enrollment: 648 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Genital Tract Mucosal Immunity, Genital Tract Microflora
Interventions: IUD placement, Levonorgestrel IUD, Copper T380A IUD; Drug
Lead sponsor: Sharon Achilles; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Fetal Alcohol Spectrum Disorders
Interventions: CARRII, CARRII Education; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 44 Years · Female only
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Cystic Fibrosis Exacerbations While on and Off Hormonal Contraception
Interventions: Non-hormonal period, Ortho-cyclen, Ethinyl estradiol/norgestimate, 0.035 mg/0.250 mg; Other · Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2014
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Bleeding, Implants, Breakthrough Bleeding
Interventions: Tamoxifen, Placebo, Tamoxifen (open label); Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 15 Years to 45 Years · Female only
Enrollment: 109 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Weight Gain, Women's Health, Obesity
Interventions: Weight-gain Prevention, Women's Health; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Contraception
Interventions: CDB-2914; Drug
Lead sponsor: Population Council; Other
Eligibility: 21 Years to 40 Years · Female only
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Trichomonas Vaginitis, Chlamydia Trachomatis, Neisseria Gonorrhoeae Infection
Interventions: Not listed
Lead sponsor: University of Pittsburgh; Other
Eligibility: 15 Years and older · Female only
Enrollment: 305 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Mental Disorders, Contraception, Chemical Teratogen Exposure
Interventions: 1-on-1 counseling; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: San Diego, California

Conditions: Healthy Women, Female Contraception
Interventions: levonorgestrel butanoate (LB) injection; Biological
Lead sponsor: Premier Research; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 136 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 7
States / cities: Davis, California • Denver, Colorado • Boston, Massachusetts + 4 more

Search by objective public record fields.

Group Versus Individual Contraceptive Counseling for Resettled African Refugee Women

Hormonal Birth Control and the Risk of Acquiring HIV

Safety & Efficacy Study of the Adiana System for Women Who Desire Permanent Birth Control (Sterilization)

Chronic Pain Risk Associated With Menstrual Period Pain

The Project Wellness Pilot Feasibility Randomized Controlled Trial

The Effect of Early Versus Traditional Follow-Up on Breastfeeding Rates at 6 Months

Prostate Specific Antigen (PSA) and Acute Failure Modes Study of the PATH Woman's Condom and FC2 Female Condom

Immediate Postpartum Nexplanon Placement in Opioid Dependent Women

Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women

Averting NAS Among Opioid-Using Young Women Receiving MAT Using Buprenorphine

EC PK in Women With Normal and Obese BMI

Study of Efficacy, Cycle Control, and Safety of a NES-E2 Contraceptive Vaginal Ring

Depo Provera Self-Administration Study: Putting a Patient-Centered Practice to the Test at Planned Parenthood

Compare Two Copper IUDs: Mona Lisa NT Cu380 Mini and ParaGard

A Trial of Group Versus Individual Family Planning Counseling in Ghana

Study of Immune Cell Changes in the Genital Tract 2 Months After Initiation of an IUD for Contraception

Contraception and Alcohol Risk Reduction Internet Intervention Randomized Trial

Contraceptive Hormones and Women With Cystic Fibrosis

Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users

Preventing Weight Gain in African American Reproductive-Aged Women

Study to Evaluate the Safety and Efficacy of Two Contraceptive Vaginal Rings Delivering a Daily Dose of 1500 or 2500 μg of CDB-2914

Non-Invasive Sexually Transmitted Disease Testing in Women Seeking Emergency Contraception or Urine Pregnancy Testing

Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions

A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception